COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation

Abstract

This study presents novel findings that miRNA 526b is a COX-2 upregulated, oncogenic miRNA promoting SLCs, the expression of which follows EP4 receptor-mediated signaling, and is a promising biomarker for monitoring and personalizing breast cancer therapy.